Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Merck
US Department of Justice
Chubb
Medtronic
Colorcon
Covington
Argus Health
Accenture

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,880,823

« Back to Dashboard

Summary for Patent: 4,880,823
Title: Injection of nicardinpine hydrochloride and process for the production thereof
Abstract:An injectable composition of nicardipine hydrochloride comprising an aqueous nicardipine hydrochloride solution containing 2-7 w/v % of polyhydric alcohol. This injectable composition can maintain its desired concentration and can be stably stored for a long period of time.
Inventor(s): Ogawa; Katayasu (Saitama, JP), Ohtani; Go (Tokyo, JP), Yokota; Shoji (Tokyo, JP), Aruga; Masayoshi (Saitama, JP)
Assignee: Yamanouchi Pharmaceutical Co., Ltd. (Tokyo, JP)
Application Number:07/338,402
Patent Claim Types:
see list of patent claims
Composition; Formulation; Process;

Drugs Protected by US Patent 4,880,823

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,880,823

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan59-102991May 22, 1984

International Patents Family Members for US Patent 4,880,823

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Spain 8700567 ➤ Try a Free Trial
Spain 543343 ➤ Try a Free Trial
European Patent Office 0162705 ➤ Try a Free Trial
Germany 3582954 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Moodys
US Army
Cantor Fitzgerald
Harvard Business School
McKesson
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.